Esperion Therapeutics
ESPR
#7490
Rank
โ‚ฌ0.30 B
Marketcap
1,53ย โ‚ฌ
Share price
5.70%
Change (1 day)
-20.06%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): โ‚ฌ6.88 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.33 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ6.87 M-104.99%
2023 -โ‚ฌ0.14 Billion-15.03%
2022 -โ‚ฌ0.17 Billion-20.61%
2021 -โ‚ฌ0.21 Billion84.28%
2020 -โ‚ฌ0.12 Billion35.75%
2019 -โ‚ฌ81.61 Million-55.71%
2018 -โ‚ฌ0.19 Billion19.57%
2017 -โ‚ฌ0.16 Billion125.39%
2016 -โ‚ฌ68.38 Million51.43%
2015 -โ‚ฌ45.16 Million36.45%
2014 -โ‚ฌ33.1 Million43.55%
2013 -โ‚ฌ23.06 Million145.26%
2012 -โ‚ฌ9.4 Million
2002 -โ‚ฌ26.8 Million-7.81%
2001 -โ‚ฌ29.07 Million15.03%
2000 -โ‚ฌ25.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.47 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.49 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.18 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.38 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ26.36 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.19 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA